Hypertrophic cardiomyopathy (HCM) patients often develop left-ventricular subendocardial ischaemia, a cause of chest symptoms, despite normal epicardial coronary arteries. The aim of this study was to examine whether ultrasonic tissue characterization or late gadolinium enhancement on cardiac magnetic resonance imaging can detect subendocardial ischaemia in patients with HCM.
Introduction
Approximately one-third to one-half of patients with hypertrophic cardiomyopathy (HCM) develop transient left-ventricular (LV) cavity dilation during stress scintigraphy despite normal epicardial arteries. 1 -5 Transient LV cavity dilation is considered to reflect subendocardial ischaemia because this scintigraphic abnormality is associated with myocardial lactate abnormalities 1 and occurs in the absence of any significant changes in LV cavity size. 1, 3 Myocardial ischaemia plays an important role in the pathophysiology of HCM, 6, 7 but non-invasive imaging techniques except for stress
scintigraphy have yet to be established for the detection of subendocardial ischaemia. Echocardiography and cardiac magnetic resonance imaging are useful modalities to assess morphology and function in patients with HCM. Furthermore, the integrated backscatter (IB) technique on echocardiography 8, 9 and late gadolinium enhancement on cardiac magnetic resonance imaging 10, 11 have been developed to non-invasively characterize myocardial tissue in clinical settings. Subendocardial ischaemia may cause changes in tissue characteristics in the subendocardium of the LV, but little data are available regarding the diagnostic performance of echocardiography and cardiac magnetic resonance imaging. Thus, we examined whether ultrasonic tissue characterization using the IB technique or late gadolinium enhancement on cardiac magnetic resonance imaging can detect subendocardial ischaemia in patients with HCM.
Methods

Study population
The present study consisted of 29 non-obstructive HCM patients with asymmetric septal hypertrophy referred to Matsushita Memorial Hospital (16 men; mean age, 60 years). Diagnosis of HCM was based on conventional echocardiographic demonstration of LV end-diastolic thickness of ≥15 mm and end-diastolic diameter of ≤55 mm in the absence of any cardiac or systemic disorder that could cause hypertrophy, such as severe hypertension or aortic stenosis. Asymmetric septal hypertrophy was defined as an end-diastolic ventricular septum to LV posterior wall thickness ratio of ≥1.5. Left-ventricular outflow obstruction was considered absent when the peak jet velocity ,2.5 m/s using the continuous wave Doppler method under resting conditions or Valsalva manoeuver in the supine position. All patients were in sinus rhythm and were in clinically stable condition; none of them had a reduced LV ejection fraction or clinically significant valvular heart disease. There were no patients treated with permanent mechanical device implantations, septal myectomy, alcohol septal ablation, or heart transplantation. Coronary heart disease was ruled out in all patients on the basis of conventional coronary angiography or multidetector computed tomography. Informed consent for this study was obtained from all patients with HCM.
Exercise scintigraphy
All patients underwent maximal symptom-limited exercise testing with myocardial scintigraphy. All medications, if any, were withdrawn for at least five half-lives before exercise testing. The exercise workload began with 25 W and was increased by 25 W every 2 min using an electrically operated sitting bicycle ergometer under continuous monitoring with a 12-lead electrocardiogram. Blood pressure was measured using arm-cuff sphygmomanometry every 2 min or more frequently. The exercise testing was finished at achievement of 85% of the maximal predicted heart rate, or due to physical exhaustion, ST-segment depression ≥0.2 mV or elevation ≥0.1 mV, systolic blood pressure ≥200 mmHg, or significant arrhythmias causing haemodynamic instability. Every exercise-induced displacement of the ST-segment was measured at 0.08 s after the J point over three consecutive beats. Positive ST-segment depression was defined as horizontal or down sloping depression ≥0.1 mV. Tc-99m tetrofosmin of 370 or 740 MBq was injected intravenously 1 min before the termination of exercise and 4 h later. Single photon emission computed tomograms were then obtained after stress and at rest every 30 min after tracer injections with a digital gamma camera equipped with a low-energy, high-resolution, parallel-hole collimator (Starcam 3000XC/T, General Electric Medical Systems, WI, USA). The camera was rotated 1808 from a 458 right anterior oblique position to a 458 left posterior oblique position. Finally, 32 images were obtained on a matrix of 64 × 64 pixels with a 30 s exposure for each 5.68 interval, and were reconstructed as single photon emission computed tomograms using a Hanning filter without correction for attenuation or scatter.
Stress and rest images were visually semiquantified in a conventional 17-segment model of the LV, including one apex segment on the vertical long-axis view and 16 segments on three short-axis views, using a standard 5-point scoring system (0 ¼ normal uptake, 1 ¼ mild reduction in tracer uptake, 2 ¼ moderate reduction, 3 ¼ severe reduction, 4 ¼ absence of detectable tracer uptake). In brief, basal and midsections were divided into six segments (anterior, anteroseptal, inferoseptal, inferior, inferolateral, anterolateral) and the apical section was divided into four segments (anterior, septal, inferior, lateral). Summed stress score and summed rest score were calculated by adding the 17 segment scores of the stress and rest images, respectively. The summed difference score was the sum of the difference between the stress score and rest score in each segment.
To assess subendocardial ischaemia, e.g. as shown in Figure 1A , transient LV cavity dilation was quantified using software that we had developed previously 3, 4 and had appropriately modified. 5 Briefly, the LV was divided into 15 short-axis slices and 100 radii were generated at 3.68 intervals from the centre of each image. An area surrounded by 100 points each displaying the maximum count on each radius was calculated automatically in the stress and rest images. The transient dilation index was defined as the stress-to-rest ratio in the sum of the 15 surface areas, and a subendocardial perfusion abnormality was considered present if the transient dilation index was .1.07.
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Echocardiography
Conventional echocardiographic examination was performed in all HCM patients using a SONOS 5500 with a wide-band sector transducer, S4 (Philips Medical Systems, Best, the Netherlands). Echocardiographic indexes were measured as: LV end-diastolic diameter, LV fractional shortening, ventricular septum and LV posterior wall thickness at the level of the chordae, left atrial end-systolic diameter, the ratio of the E wave to the A wave, and the deceleration time of the E wave through a mitral valve. Ultrasonic IB analysis was performed in 16 patients using the online acoustic densitometry software as previously described. 12, 13 In brief, IB images were obtained from the parasternal short-axis view at the level of the chordae, and stored on a magneto-optical disk with maximum dynamic range of 60 dB and 60 image frames corresponding to almost two cardiac cycles. The maximum circle as the region of interest was put on the whole of the anterior ventricular septum, the right and left halves of the anterior ventricular septum, and the whole of the LV posterior wall, excluding endocardial and epicardial reflectors. 14, 15 Each region of interest was manually adjusted on a frame-by-frame basis to keep it inside each region throughout cardiac cycles, excluding endocardial and epicardial reflectors. The time-gain compensation levels were all equal and lateral-gain compensation was not used. The pre-processing, focus position, persistence, compression, frame rate, and post-processing were maintained constant in all patients, avoiding the signal saturation that may cause estimation errors. Based on the time-intensity curves, we measured the cyclic variation magnitude of IB (CV-IB) defined as the difference between the minimum and maximum values during cardiac cycles ( Figure 1B ). An experienced investigator who was unaware of scintigraphic findings did CV-IB analysis.
Cardiac magnetic resonance
Gadolinium-enhanced cardiac magnetic resonance imaging was performed in 22 patients with HCM, as shown in Figure 1C . All magnetic resonance images were acquired using a 1.5 T imaging system (Signa HDx, General Electric Medical Systems, WI, USA). As in the scintigraphic analysis described earlier, three short-axis images at the basal-, mid-, and apical-LV levels and a long-axis image of the apex segment were obtained
Ultrasonic tissue characterization and ischaemia in HCM under serial breath-holds using a 2-dimensional, spoiled, and segmented inversion recovery and gradient-echo sequence 10 min after an intravenous injection of 0.1 mmol/kg gadopentetate dimeglumine (Magnevist, Schering AG, Berlin, Germany). Inversion time was selected using a standardized algorithm on the basis of myocardial, blood T1 values, heart-rate, time of imaging from contrast injection, and dose of contrast administered. The following scan parameters were used: slice thickness 7 mm, field of view 360 × 360 mm, flip angle 208, spatial resolution 1.6 × 2.3 mm, number of averages, 2. Late gadolinium enhancement in the whole of the ventricular septum, in the right and left halves of the ventricular septum, and in the whole of the LV posterior wall were determined on the basis of a 17-segment model of the LV. The areas of ventricular septum-free wall junctions, defined to be located between the two radii each making an angle of 308 with the junction line on opposite side, 16 were excluded from the analysis because junction areas have been reported to be different from the ventricular septum in terms of histology 17 and because we calculated CV-IB in the segment of the ventricular septum without junction areas. Late gadolinium enhancement was defined as two standard deviations above the mean signal intensity of apparently normal myocardium. 18 Furthermore, when late gadolinium enhancement was present in the ventricular septum, it was visually assessed in terms of predominance, i.e. rightdominance or left-dominance. Experienced investigators who were unaware of the scintigraphic findings analysed gadolinium-enhanced cardiac magnetic resonance images. Disagreements were resolved by consensus.
Statistical analysis
Categorical variables were compared by x 2 test or Fisher's exact test as appropriate. Continuous variables were expressed as the mean + standard deviation and compared using the Student's t-test. Scintigraphic scores and CV-IB indexes were expressed as the mean + standard error and compared using the Mann-Whitney U test because of the skewed distributions. Wilcoxon's matched pairs signed ranks test was used to analyse CV-IB indexes within each group. Spearman rank correlation coefficient was used to examine correlations between transient dilation index on scintigraphy and echocardiographic variables. Receiver operator characteristics curve analysis was performed to determine the optimal cutoff point. Intraobserver and interobserver reproducibility for CV-IB were evaluated in two-layer analysis of the ventricular septum using mean absolute differences in the first 10 HCM patients enrolled in the present study. A two-sided P-value ,0.05 was considered statistically significant. All calculations were performed using SPSS version 11.0 (SPSS Inc., IL, USA).
Results
Exercise testing was performed without any complications in all HCM patients except for one patient who developed transient atrial fibrillation during the cool-down period after peak exercise. Maximum workload and maximum rate-pressure product in all patients ranged widely from 50-125 W(mean, 97 W) and from 14 200 to 39 216 (mean, 25 514), respectively. The average subendocardial ischaemia index was 1.12, ranging from 0.90 to 1.36; in all, 17 (59%) patients were diagnosed as having subendocardial ischaemia on the basis of exercise scintigraphy. Patients with or without subendocardial ischaemia did not significantly differ with respect to baseline characteristics or conventional echocardiographic findings, except that subendocardial T. Kawasaki et al. ischaemia was associated with more symptoms and with larger left-atrial diameter ( Table 1) . Transient dilation indexes were correlated with left-atrial diameters (correlation coefficient ¼ 0.67, P ¼ 0.003), but not with values of LV end-diastolic diameter, LV fractional shortening, ventricular septum and LV posterior wall thickness, the ratio of the E wave to the A wave, and the deceleration time of the E wave through a mitral valve (all P . 0.3).
Of all, 16 patients with HCM underwent ultrasonic tissue characterization; CV-IB values in the right and left halves of the anterior ventricular septum, and the whole of the LV posterior wall were obtained in all 16 patients. CV-IB was significantly lower in the whole of the ventricular septum (5.4 + 0.5 dB) than those in the whole of the LV posterior wall (10.2 + 0.8 dB, P , 0.01). No difference was observed between CV-IB in the right halves of ventricular septum (7.0 + 0.6 dB) and CV-IB in the left halves (7.0 + 0.8 dB, P ¼ 0.58), although each value was lower than those in the whole of the LV posterior wall (both P , 0.01). Of all 16 patients, 10 (63%) were diagnosed as having subendocardial ischaemia based on exercise scintigraphy. Heart rate during the acquisition of IB images was similar between patients with subendocardial ischaemia (66 + 4 bpm) and patients without subendocardial ischaemia (64 + 15 bpm, P ¼ 0.76). CV-IB in the right halves of the ventricular septum was predominant in patients with subendocardial ischaemia, whereas a reverse predominance of CV-IB was observed in patients without subendocardial ischaemia, with no statistical significance ( Table 2) . CV-IB in the whole of the ventricular septum and LV posterior wall were similar between the two groups. As shown in Figure 2 , the ratio of CV-IB in the right halves to the left halves was significantly higher in patients with subendocardial ischaemia (1.19 + 0.10) than those without (0.84 + 0.10, P ¼ 0.04). Similarly, the difference in CV-IB from the right halves to the left halves of the Ultrasonic tissue characterization and ischaemia in HCM ventricular septum was higher in patients with subendocardial ischaemia (1.6 + 0.5 dB) than without subendocardial ischaemia (21.1 + 1.2 dB, P ¼ 0.05). Of all 22 patients who underwent cardiac magnetic resonance, eight (36%) showed late gadolinium enhancement in areas including the ventricular septum or LV posterior wall: eight in the whole of the ventricular septum; five in the right half of the ventricular septum; four in the left half of the ventricular septum, but none in the whole of the LV posterior wall. Of all 22 patients, 11 (50%) were diagnosed as having subendocardial ischaemia on the basis of exercise scintigraphy. The location of late gadolinium enhancement did not differ between patients with and without subendocardial ischaemia ( Table 3) . Late gadolinium enhancement of the ventricular septum was right-dominated in three patients and left-dominated in two among those with subendocardial ischaemia, and right-dominated in two and left-dominated in two among patients without subendocardial ischaemia (P ¼ 0.64).
Both ultrasonic tissue characterization and gadolinium enhanced cardiac magnetic resonance imaging were performed in nine patients with HCM, four of whom were diagnosed as having subendocardial ischaemia on the basis of exercise scintigraphy. Late gadolinium enhancement was detected in two of the four patients; one showed late gadolinium enhancement in the right half of the ventricular septum with a CV-IB of 6.0 dB and 11.8 dB in the left half, while the other showed late gadolinium enhancement in the left half of the ventricular septum with a CV-IB of 6.2 dB in the right half and 5.6 dB in the left half. None of the remaining five patients without subendocardial ischaemia showed late gadolinium enhancement.
Receiver operator characteristics curve analysis to detect subendocardial ischaemia showed that the optimal cutoff was 1.0 for the ratio of CV-IB in the right halves to the left halves and 0 dB of the difference from the right halves to the left halves (Figure 3) . The ratio of CV-IB .1.0 or the difference in CV-IB .0 dB showed equally good predictive values in detecting subendocardial ischaemia: a sensitivity of 80%, a specificity of 71%, an accuracy of 76%, a positive predictive value of 80%, and a negative predictive value of 71% in both cutoffs.
Intraobserver and interobserver variability of CV-IB were good, with a small difference in mean values in the right halves of ventricular septum (1.0 + 0.4 and 1.6 + 0.5 dB) and in the left halves (0.4 + 0.4 and 0.5 + 0.4 dB) in 10 HCM patients. Of the 10 patients, four showed a ratio of CV-IB in the right halves to the left halves .1.0, while four patients showed a difference of .0 dB, at the initial examination. Intraobserver and interobserver variability did not lead to any change in classification of the 10 patients according to the cutoff point of the ratio of CV-IB .1.0 or the difference of CV-IB .0 dB.
Discussion
The present study showed that subendocardial ischaemia was frequently observed in non-obstructive HCM patients with asymmetric septal hypertrophy, and that subendocardial ischaemia was associated with the predominant CV-IB in the right halves of the ventricular septum, when compared with the left halves. The ratio of CV-IB in the right halves to the left halves of the ventricular septum .1.0 or a difference in CV-IB from the right halves to the left halves .0 dB showed a good diagnostic performance for the detection of subendocardial ischaemia in HCM patients. On the other hand, late gadolinium enhancement on cardiac magnetic resonance imaging was not associated with subendocardial ischaemia in our cohort.
CV-IB in the right halves and the left halves of the ventricular septum did not differ significantly in all patients who underwent ultrasonic tissue characterization. This finding is consistent with previous studies using CV-IB separately in the right halves and left halves of the ventricular septum in patients with HCM. 14, 19 However, in the present study, subgroup analysis dichotomized by the presence or absence of subendocardial ischaemia revealed an association between the predominance of CV-IB in the ventricular septum and subendocardial ischaemia in patients with HCM. Pingitore et al. 15 examined dipyridamole-induced changes in CV-IB in patients with HCM, and found that CV-IB during dipyridamole infusion was significantly reduced, when compared with resting values, in the left halves of the ventricular septum, but did not change in the right halves of the ventricular septum or the whole of the LV posterior wall. In our study, the diagnostic performance of CV-IB for subendocardial ischaemia was good even on resting echocardiography, which is preferable to stress echocardiography because of its simplicity and convenience in clinical practice. Myocardial ischaemia has been reported to be a determinant of IB in experimental studies. 20, 21 CV-IB in the whole LV wall was reduced during exercise or rapid pacing in patients with coronary artery disease. 22, 23 In addition, chronic myocardial ischaemia seems to reduce CV-IB not only during stress, but also at rest in patients with coronary artery disease. Pasquet et al. 24 examined CV-IB in patients with chronic coronary artery disease and LV dysfunction, and found that CV-IB at rest was low in dysfunctional segments, when compared with normally contracting segments, in which CV-IB increased parallel to the contractile reserve during dobutamine echocardiography. Furthermore, in patients receiving angioplasty for chronic coronary artery disease studied by Lin et al., 25 a reduction in CV-IB at rest was identified not only in dysfunctional segments with a contractile reserve, but also in normally contracting segments with ischaemic burden; the reduction in CV-IB recovered soon after angioplasty in both segments. Thus, we may safely consider that repetitive subendocardial ischaemia causes the reduction in resting CV-IB in the left halves of the ventricular septum in patients with HCM, although the mechanisms of subendocardial ischaemia in HCM are, in part, different from myocardial ischaemia in patients with coronary artery disease.
In the present magnetic resonance study, among 11 HCM patients with subendocardial ischaemia, only two (18%) showed late gadolinium enhancement in the left halves of the ventricular septum. Furthermore, late gadolinium enhancement on cardiac magnetic resonance imaging was not associated with subendocardial ischaemia. Late gadolinium enhancement has been established as the most reliable non-invasive imaging method for assessing myocardial fibrosis. 10, 11 Thus, our findings indicate that repetitive subendocardial ischaemia is unlikely to cause replacement myocardial fibrosis in patients with HCM. Recently, cardiac magnetic resonance stress testing, e.g. adenosine stress perfusion imaging or dobutamine stress wall motion analysis, was reported to demonstrate a high diagnostic accuracy for the detection of significant coronary artery disease, 26 although these techniques have not been popular in the clinical setting. Further studies are needed to clarify whether stress cardiac magnetic resonance detects subendocardial ischaemia in patients with HCM.
Clinical implications
Myocardial ischaemia is a major cause of chest symptoms in HCM. 6 Inability of the coronary microcirculation to respond to the increased oxygen demand of the hypertrophied myocardium may lead to chest symptoms in HCM patients without epicardial coronary artery disease. 27 The frequency of symptoms in the present study was significantly lower in patients without subendocardial ischaemia than in those with subendocardial ischaemia, suggesting that subendocardial ischaemia can cause some symptoms. Some calcium antagonists, e.g. verapamil 28 and diltiazem, 29 have been reported to have reduced or prevented subendocardial ischaemia, even in patients with non-obstructive HCM, without negatively affecting exercise tolerance. Ultrasonic tissue characterization using CV-IB may be useful in selecting HCM patients who will benefit from medications to reduce symptoms.
Study limitations
The present study was conducted in a single centre and the size was not large enough to extrapolate the present result to a community-based population. Not all patients underwent both ultrasonic tissue characterization and cardiac magnetic resonance Ultrasonic tissue characterization and ischaemia in HCM mainly because this study was conducted in routine clinical practice. However, we were able to obtain meaningful data of ultrasonic tissue characterization for detecting subendocardial ischaemia in patients with HCM.
Conclusion
Ultrasonic tissue characterization using CV-IB separately in the right and left halves of the ventricular septum, but not late gadolinium enhancement on cardiac magnetic resonance imaging, provided useful information for detecting subendocardial ischaemia in patients with HCM. Ultrasonic tissue characterization may be useful in selecting HCM patients who will benefit from medications to relieve chest symptoms.
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